The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: Secondary analysis of RTOG 98-02.
Roshan Sudhir Prabhu
No relevant relationships to disclose
Minhee Won
No relevant relationships to disclose
Edward G. Shaw
No relevant relationships to disclose
Meihua Wang
No relevant relationships to disclose
David Brachman
No relevant relationships to disclose
Minesh P. Mehta
Employment or Leadership Position - Pharmacyclics
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Elekta; Merck; Novartis; Quark; Tomotherapy; US Oncology; Vertex
Stock Ownership - Accuray; Colby; Pharmacyclics; ProCertus; Stemina
Honoraria - Grace; MDM; Merck; Prime Oncology; Strategic Edge; WebMD